Replies to post #503513 on Anavex Life Sciences Corp (AVXL)

[kevindenver]

Thx for the providing the info from 2023, no wonder I don't recall it as I don't remember such a statement repeated in a PR or the 10-K.

It should be noted that forward looking statement in an earnings call was made soon after the preliminary data release and before full consultation and feedback with the KOL's (Key Opinion Leaders) and right around when Marwan Sabbagh joined as Chairman of the Scientific Advisory Board.

https://www.anavex.com/post/anavex-announces-appointment-of-dr-marwan-n-sabbagh-md-as-chairman-of-the-scientific-advisory-board

IMO and the KOL's, the long term OLE has served the intended purpose to provide the confirmatory data and further prove out the genetic factors we see today in the ABCLEAR subgroups.

In addition, quote provided made no mention of what type of study and the OLE may very well have been what was meant by the statement. Not another P3 RCT as you seem to think it meant.

[williamssc]

So in parallel with approval they run a confirmatory Phase 4. A lot of information has evolved and a better understanding of the data. It's now onward with full approval EMA application. Amazing.